Comparison of Heparin Types; Efficacy and Safety
NCT01343381 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2012-05-15
Summary
Heparin, a blood thinner, is used routinely in Open-heart surgery. Do different brands of this drug have differing clinical effects despite both having exactly the same regulation and marketing specifications?
Conditions
Interventions
- DRUG
-
Hepalean Heparin
400 units per kilogram bolus prior to initiation of CPB
- DRUG
-
PPC Heparin
400 unit per kilogram bolus prior to initiation of CPB
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kevin H Teoh, MD · Hamilton Health Sciences: Hamilton General Site
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Comparison of Two Dosages of Heparin Before Extracorporeal Circulation
NCT03752437 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
NCT01810237 ·Status: WITHDRAWN ·Phase: NA
-
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
NCT00735189 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
NCT02132689 ·Status: COMPLETED ·Phase: PHASE4
-
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
NCT00216866 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
NCT00311753 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
NCT02334007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Effectiveness of Oral Anticoagulants
NCT01847547 ·Status: COMPLETED
-
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
NCT00260988 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
NCT00451412 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients
NCT00934167 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
NCT03506815 ·Status: COMPLETED ·Phase: PHASE3
-
Assays for and Reversal of New Anticoagulants
NCT01795781 ·Status: COMPLETED
-
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
NCT05426031 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
NCT06096116 ·Status: RECRUITING ·Phase: PHASE3
-
Recanalization Rate of Acute DVT
NCT06145269 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
NCT03988231 ·Status: WITHDRAWN ·Phase: PHASE4
-
HEParin Antagonisation in Transcatheter Aortic Valve Implantation
NCT05422170 ·Status: UNKNOWN
-
Anticoagulation Length in Cancer Associated Thrombosis
NCT01817257 ·Status: TERMINATED ·Phase: PHASE2
-
Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
NCT03426982 ·Status: UNKNOWN ·Phase: PHASE4
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
NCT00435487 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography
NCT01260519 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638 ·Status: UNKNOWN ·Phase: PHASE3